Published in J Exp Med on February 01, 1996
Accelerated neutrophil apoptosis in mice lacking A1-a, a subtype of the bcl-2-related A1 gene. J Exp Med (1998) 1.75
The small molecule GMX1778 is a potent inhibitor of NAD+ biosynthesis: strategy for enhanced therapy in nicotinic acid phosphoribosyltransferase 1-deficient tumors. Mol Cell Biol (2009) 1.60
312-nanometer ultraviolet B light (narrow-band UVB) induces apoptosis of T cells within psoriatic lesions. J Exp Med (1999) 1.38
Failure of poly(ADP-ribose) polymerase cleavage by caspases leads to induction of necrosis and enhanced apoptosis. Mol Cell Biol (1999) 1.35
PARP-1 inhibits glycolysis in ischemic kidneys. J Am Soc Nephrol (2008) 1.02
Expression of Pseudomonas aeruginosa toxin ExoS effectively induces apoptosis in host cells. Infect Immun (2006) 0.99
Activation of CPP32-like proteases is not sufficient to trigger apoptosis: inhibition of apoptosis by agents that suppress activation of AP24, but not CPP32-like activity. J Exp Med (1997) 0.93
Caspase-3 activation during apoptosis caused by glutathione-doxorubicin conjugate. Br J Cancer (1999) 0.82
The Role of Nicotinamide Phosphoribosyltransferase in Cerebral Ischemia. Curr Top Med Chem (2015) 0.76
Low nicotinamide mononucleotide adenylyltransferase activity in a tiazofurin-resistant cell line: effects on NAD metabolism and DNA repair. Br J Cancer (1997) 0.75
Apoptosis in the pathogenesis and treatment of disease. Science (1995) 20.24
(ADP-ribose)n participates in DNA excision repair. Nature (1980) 3.76
Poly(ADP-ribose) in the cellular response to DNA damage. Radiat Res (1985) 3.52
Inhibition of apoptosis during development of colorectal cancer. Cancer Res (1995) 2.77
Patterns of cell death. Methods Achiev Exp Pathol (1988) 2.30
Fas antigen and p55 TNF receptor signal apoptosis through distinct pathways. J Immunol (1994) 2.06
Divergent signalling via APO-1/Fas and the TNF receptor, two homologous molecules involved in physiological cell death. EMBO J (1994) 2.05
Apoptosis: a different type of cell death. FASEB J (1992) 1.99
Mechanism of deoxyadenosine and 2-chlorodeoxyadenosine toxicity to nondividing human lymphocytes. J Clin Invest (1985) 1.98
Hydrogen peroxide-induced injury of cells and its prevention by inhibitors of poly(ADP-ribose) polymerase. Proc Natl Acad Sci U S A (1986) 1.87
DNA strand breaks, NAD metabolism, and programmed cell death. Exp Cell Res (1986) 1.60
Tumor necrosis factor-mediated cytotoxicity involves ADP-ribosylation. J Immunol (1988) 1.24
Possible involvement of poly(ADP-ribosyl) polymerase in triggering stress-induced apoptosis. Exp Cell Res (1994) 1.18
Apoptosis and DNA fragmentation precede TNF-induced cytolysis in U937 cells. J Cell Biochem (1992) 1.13
Inhibition of apoptosis as a mechanism of tumor promotion. FASEB J (1994) 1.09
Purification of a 24-kD protease from apoptotic tumor cells that activates DNA fragmentation. J Exp Med (1994) 1.01
The effect of growth conditions on NAD+ and NADH concentrations and the NAD+:NADH ratio in normal and transformed fibroblasts. J Biol Chem (1974) 0.99
Lymphocyte dysfunction after DNA damage by toxic oxygen species. A model of immunodeficiency. J Exp Med (1986) 0.99
Acylamino boronic acids and difluoroborane analogues of amino acids: potent inhibitors of chymotrypsin and elastase. J Med Chem (1985) 0.98
Meta-iodobenzylguanidine (MIBG), a novel high-affinity substrate for cholera toxin that interferes with cellular mono(ADP-ribosylation). Biochim Biophys Acta (1990) 0.90
Inhibition of poly(ADP-ribose) polymerase as a possible reason for activation of Ca2+/Mg2+-dependent endonuclease in thymocytes of irradiated rats. Int J Radiat Biol Relat Stud Phys Chem Med (1988) 0.88
VP-16-induced nucleotide pool changes and poly(ADP-ribose) synthesis: the role of VP-16 in interphase death. Exp Cell Res (1989) 0.84
The role of DNA damage and inhibition of poly(ADP-ribosyl)ation in loss of clonogenicity of murine L929 fibroblasts, caused by photodynamically induced oxidative stress. Cancer Res (1994) 0.83
Inhibitors of ADP-ribose polymerase decrease the resistance of HER2/neu-expressing cancer cells to the cytotoxic effects of tumor necrosis factor. J Immunol (1991) 0.82
Antimetastatic activity of boro-amino acid analog protease inhibitors against B16BL6 melanoma in vivo. Invasion Metastasis (1992) 0.80
Glucocorticoid-induced cell death and poly[adenosine diphosphate(ADP)-ribosyl]ation: increased toxicity of dexamethasone on mouse S49.1 lymphoma cells with the poly(ADP-ribosyl)ation inhibitor benzamide. Endocrinology (1986) 0.79
Competitive PCR. Nature (1992) 5.96
Modulation of cell surface iron transferrin receptors by cellular density and state of activation. J Supramol Struct (1979) 3.02
Tumor necrosis factor stimulates interleukin-1 and prostaglandin E2 production in resting macrophages. Biochem Biophys Res Commun (1986) 2.96
Autoinducer of virulence as a target for vaccine and therapy against Staphylococcus aureus. Science (1998) 2.26
Message amplification phenotyping (MAPPing): a technique to simultaneously measure multiple mRNAs from small numbers of cells. Biotechniques (1990) 2.22
Characterization of a human macrophage-like cell line stimulated in vitro: a model of macrophage functions. J Immunol (1980) 2.06
Acute in vivo effects of human recombinant tumor necrosis factor. Lab Invest (1987) 2.06
In vitro activation of a human macrophage-like cell line. Nature (1979) 2.05
Enhancement of neutrophil superoxide production by preincubation with recombinant human tumor necrosis factor. J Immunol (1987) 1.97
Native interleukin 1 inhibitors. Immunol Today (1989) 1.92
PCR MIMICS: competitive DNA fragments for use as internal standards in quantitative PCR. Biotechniques (1993) 1.89
Recombinant tumor necrosis factor causes activation of human granulocytes. Blood (1987) 1.62
Is Reye's syndrome caused by augmented release of tumour necrosis factor? Lancet (1986) 1.54
Tumor necrosis factor causes increased pulmonary permeability and edema. Comparison to septic acute lung injury. Am Rev Respir Dis (1988) 1.54
Transferrin receptors on human B and T lymphoblastoid cell lines. Biochim Biophys Acta (1979) 1.44
Regulation of neutrophil interleukin 8 gene expression and protein secretion by LPS, TNF-alpha, and IL-1 beta. J Cell Physiol (1993) 1.39
Antibiotic therapy, endotoxin concentration in cerebrospinal fluid, and brain edema in experimental Escherichia coli meningitis in rabbits. J Infect Dis (1987) 1.33
Nicotine inhibition of apoptosis suggests a role in tumor promotion. FASEB J (1993) 1.29
Co-migration and internalization of transferrin and its receptor on K562 cells. J Cell Biol (1983) 1.26
Construction of cDNA libraries from small numbers of cells using sequence independent primers. Nucleic Acids Res (1989) 1.24
Apoptosis and DNA fragmentation precede TNF-induced cytolysis in U937 cells. J Cell Biochem (1992) 1.13
Characterization of a rabbit cationic protein (CAP18) with lipopolysaccharide-inhibitory activity. Infect Immun (1994) 1.12
Natural killer lines and clones with apparent antigen specificity. J Exp Med (1990) 1.10
Antibody engineering by parsimonious mutagenesis. Gene (1993) 1.09
Inhibition of apoptosis as a mechanism of tumor promotion. FASEB J (1994) 1.09
Modulation of adipocyte differentiation by tumor necrosis factor and transforming growth factor beta. J Cell Biol (1989) 1.07
Calmodulin-dependent protein kinase II mediates signal transduction in apoptosis. FASEB J (1997) 1.07
Cloning of the cDNA for the serine protease homolog CAP37/azurocidin, a microbicidal and chemotactic protein from human granulocytes. J Immunol (1991) 1.06
Evaluation of antimicrobial and lipopolysaccharide-neutralizing effects of a synthetic CAP18 fragment against Pseudomonas aeruginosa in a mouse model. Antimicrob Agents Chemother (1998) 1.06
Association of systemic immune complexes, complement activation, and antibodies to Pseudomonas aeruginosa lipopolysaccharide and exotoxin A with mortality in cystic fibrosis. Am Rev Respir Dis (1986) 1.06
Modulation of tumor necrosis factor-alpha gene expression. Desensitization of prostaglandin E2-induced suppression. J Immunol (1989) 1.05
Direct cDNA cloning of the rearranged immunoglobulin variable region. Biotechniques (1989) 1.05
Granulocyte depletion prevents tumor necrosis factor-mediated acute lung injury in guinea pigs. Am Rev Respir Dis (1988) 1.04
Smoking and neurogenerative diseases. Lancet (1993) 1.04
Human monoclonal antibodies that recognize conserved epitopes in the core-lipid A region of lipopolysaccharides. J Clin Invest (1987) 1.03
Role of circulating endotoxin and interleukin-6 in the ACTH and corticosterone response to intraperitoneal LPS. Am J Physiol (1997) 1.03
Purification of a 24-kD protease from apoptotic tumor cells that activates DNA fragmentation. J Exp Med (1994) 1.01
Identification of functional and structural amino-acid residues by parsimonious mutagenesis. Gene (1996) 0.99
Lipid peroxidation and formation of 8-hydroxydeoxyguanosine from acute doses of halogenated acetic acids. Fundam Appl Toxicol (1996) 0.99
The solution structure of the active domain of CAP18--a lipopolysaccharide binding protein from rabbit leukocytes. FEBS Lett (1995) 0.99
Transferrin receptors on leukaemic cells. Lancet (1980) 0.99
Acylamino boronic acids and difluoroborane analogues of amino acids: potent inhibitors of chymotrypsin and elastase. J Med Chem (1985) 0.98
Mechanisms that regulate the production and effects of tumor necrosis factor-alpha. Crit Rev Immunol (1989) 0.96
CAP 37, a 37 kD human neutrophil granule cationic protein shares homology with inflammatory proteinases. Life Sci (1990) 0.94
Role of protein phosphorylation in TNF-induced apoptosis: phosphatase inhibitors synergize with TNF to activate DNA fragmentation in normal as well as TNF-resistant U937 variants. J Cell Biochem (1993) 0.94
Primer design for the cloning of immunoglobulin heavy-chain leader-variable regions from mouse hybridoma cells using the PCR. Biotechniques (1991) 0.94
Snake venom antibodies in Ecuadorian Indians. J Trop Med Hyg (1981) 0.94
Activation of CPP32-like proteases is not sufficient to trigger apoptosis: inhibition of apoptosis by agents that suppress activation of AP24, but not CPP32-like activity. J Exp Med (1997) 0.93
Variable region sequences of a protective human monoclonal antibody specific for the Haemophilus influenzae type b capsular polysaccharide. Infect Immun (1994) 0.92
Human monoclonal antibodies specific for capsular polysaccharides of Klebsiella recognize clusters of multiple serotypes. J Immunol (1991) 0.91
Haloacetate-induced oxidative damage to DNA in the liver of male B6C3F1 mice. Toxicology (1996) 0.91
Interaction of CAP18-derived peptides with membranes made from endotoxins or phospholipids. Biophys J (2001) 0.91
Acquired iron-deficiency anemia caused by an antibody against the transferrin receptor. N Engl J Med (1984) 0.90
Endotoxin-binding synthetic peptides with endotoxin-neutralizing, antibacterial and anticoagulant activities. Prog Clin Biol Res (1994) 0.90
Tumor cell resistance to apoptosis due to a defect in the activation of sphingomyelinase and the 24 kDa apoptotic protease (AP24). FASEB J (1996) 0.90
Serologic and molecular characterization of a human monoclonal rheumatoid factor derived from rheumatoid synovial cells. Arthritis Rheum (1990) 0.89
Antibody engineering at the millennium. Biotechniques (2000) 0.89
Incorporation of LPS in liposomes diminishes its ability to induce tumoricidal activity and tumor necrosis factor secretion in murine macrophages. J Leukoc Biol (1988) 0.88
Receptor-mediated endocytosis of human transferrin and its cell surface receptor. J Cell Physiol (1985) 0.88
Snake bite among the Waorani Indians of Eastern Ecuador. Trans R Soc Trop Med Hyg (1978) 0.86
Prospects for the therapeutic use of human monoclonal antibodies. J Biol Response Mod (1986) 0.86
A derivative of cationic antimicrobial protein attenuates lung injury by suppressing cell adhesion. Am J Respir Cell Mol Biol (1996) 0.85
Bcl-2-mediated resistance to apoptosis is associated with glutathione-induced inhibition of AP24 activation of nuclear DNA fragmentation. Cancer Res (1998) 0.84
Chemotherapeutic drug activation of the AP24 protease in apoptosis: requirement for caspase 3-like-proteases. Biochem Biophys Res Commun (1998) 0.83
Pentoxifylline prevents tumor necrosis factor-induced lung injury. Am Rev Respir Dis (1989) 0.83
Effects of anti-C5a antibodies on human polymorphonuclear leukocyte function: chemotaxis, chemiluminescence, and lysosomal enzyme release. J Biol Response Mod (1989) 0.83
Selective inhibition of the growth of human erythroid bursts by monoclonal antibodies against transferrin or the transferrin receptor. Blood (1986) 0.83
Stimulation of prostaglandin E2 and thromboxane B2 production by human monocytes in response to interleukin-2. Biochem Biophys Res Commun (1987) 0.83
Molecular mechanisms of interaction of rabbit CAP18 with outer membranes of gram-negative bacteria. Biochemistry (1999) 0.83
Hybrid IgA2/IgG1 antibodies with tailor-made effector functions. Clin Immunol (2001) 0.82
An improved assay for the detection of interleukin 1. J Immunol Methods (1985) 0.82
Isolation and characterization of a human monoclonal antibody that recognizes epitopes shared by Pseudomonas aeruginosa immunotype 1, 3, 4, and 6 lipopolysaccharides. Infect Immun (1989) 0.82
Human neutrophil granule cationic protein CAP37 is a specific macrophage chemotaxin that shares homology with inflammatory proteinases. Adv Exp Med Biol (1991) 0.81
Synthesis and preliminary biological evaluations of CC-1065 analogues: effects of different linkers and terminal amides on biological activity. J Med Chem (2000) 0.81
Variable region sequence modulates periplasmic export of a single-chain Fv antibody fragment in Escherichia coli. Biotechniques (1995) 0.81
Infectious disease patterns in the Waorani, an isolated Amerindian population. Am J Trop Med Hyg (1980) 0.81
Clinical trial of a plant-derived antibody on recolonization of mutans streptococci. Caries Res (2005) 0.81
Structure and functions of endotoxin-binding peptides derived from CAP18. Prog Clin Biol Res (1995) 0.81
Antimicrobial action of rabbit leukocyte CAP18(106-137). Antimicrob Agents Chemother (1997) 0.81
Mechanisms of action of rabbit CAP18 on monolayers and liposomes made from endotoxins or phospholipids. J Membr Biol (2000) 0.80
Hyperimmunoglobulinemia E in the Waorani, an isolated Amerindian population. Am J Trop Med Hyg (1980) 0.80
Characterization of human hybridomas secreting antibody to tetanus toxoid. Proc Natl Acad Sci U S A (1983) 0.79
Markers of genetic variation among the Waorani Indians of the Ecuadorian Amazon headwaters. Am J Phys Anthropol (1985) 0.78
Population differences in cutaneous methacholine reactivity and circulating IgE concentrations. J Allergy Clin Immunol (1985) 0.78
Protective effect of snake venom antibodies in sera of previous snake bite victims. Ann Trop Med Parasitol (1983) 0.78
Murine monoclonal antibodies defining neutralizing epitopes on tumor necrosis factor. Hybridoma (1987) 0.78
Human monoclonal antibodies to Pseudomonas aeruginosa type-specific lipopolysaccharides, toxin A and Klebsiella capsular polysaccharides. Dev Biol Stand (1990) 0.78
Does hyperimmunoglobulinemia-E protect tropical populations from allergic disease? J Allergy Clin Immunol (1983) 0.77
Systematic generation of antigen specific human monoclonal antibodies with therapeutical activities using active immunization. Hum Antibodies Hybridomas (1990) 0.77